atai Life Sciences (ATAI)
(Delayed Data from NSDQ)
$1.22 USD
-0.04 (-3.17%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $1.22 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
atai Life Sciences N.V. (ATAI) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$8.67 | $15.00 | $5.00 | 588.10% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for atai Life Sciences N.V. comes to $8.67. The forecasts range from a low of $5.00 to a high of $15.00. The average price target represents an increase of 588.1% from the last closing price of $1.26.
Analyst Price Targets (3 )
Broker Rating
atai Life Sciences N.V. currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on five recommendations.
Of the five recommendations deriving the current ABR, five are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 5 | 5 | 5 | 5 | 5 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/31/2024 | H.C. Wainwright & Co. | Patrick Trucchio | Strong Buy | Strong Buy |
4/4/2024 | Cantor Fitzgerald & Co | Charles C Duncan | Strong Buy | Strong Buy |
4/3/2024 | Maxim Group | Michael Okunewitch | Hold | Strong Buy |
4/1/2024 | Cowen & Co. | Ritu S Baral | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 5 |
Average Target Price | $8.67 |
LT Growth Rate | NA |
Industry | Medical - Outpatient and Home Healthcare |
Industry Rank by ABR | 46 of 253 |
Current Quarter EPS Est: | -0.15 |
ATAI FAQs
atai Life Sciences N.V. (ATAI) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 5 brokerage firms.
The average price target for atai Life Sciences N.V. (ATAI) is $8.67. The current on short-term price targets is based on 4 reports.
The forecasts for atai Life Sciences N.V. (ATAI) range from a low of $5 to a high of $15. The average price target represents a increase of $610.66 from the last closing price of $1.22.
The current UPSIDE for atai Life Sciences N.V. (ATAI) is 610.66%
Based on short-term price targets offered by three analysts, the average price target for atai Life Sciences N.V. comes to $8.67. The forecasts range from a low of $5.00 to a high of $15.00. The average price target represents an increase of 588.1% from the last closing price of $1.26.